Home / Publications / Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan

Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan

Nadezhda A Troitskaya-Markova 1
Nadezhda A Troitskaya-Markova
, 
Olga G Vlasova 1
Olga G Vlasova
, 
Tamara Ivanovna Godovikova 1
Tamara Ivanovna Godovikova
, 
Sergei Grigorievich Zlotin 1
Sergei Grigorievich Zlotin
, 
Oleg Alexeevich Rakitin 1
Oleg Alexeevich Rakitin
10.1016/j.mencom.2017.09.005
Published 2017-09-07
Communication , Volume 27, Issue 5, 448-450
12
Share
Cite this
GOST
 | 
Cite this
GOST Copy
Troitskaya-Markova N. A. et al. Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan // Mendeleev Communications. 2017. Vol. 27. No. 5. pp. 448-450.
GOST all authors (up to 50) Copy
Troitskaya-Markova N. A., Vlasova O. G., Godovikova T. I., Zlotin S. G., Rakitin O. A. Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan // Mendeleev Communications. 2017. Vol. 27. No. 5. pp. 448-450.
RIS
 | 
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.mencom.2017.09.005
UR - https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.09.005
TI - Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan
T2 - Mendeleev Communications
AU - Troitskaya-Markova, Nadezhda A
AU - Vlasova, Olga G
AU - Godovikova, Tamara Ivanovna
AU - Zlotin, Sergei Grigorievich
AU - Rakitin, Oleg Alexeevich
PY - 2017
DA - 2017/09/07
PB - Mendeleev Communications
SP - 448-450
IS - 5
VL - 27
ER -
BibTex
 | 
Cite this
BibTex (up to 50 authors) Copy
@article{2017_Troitskaya-Markova,
author = {Nadezhda A Troitskaya-Markova and Olga G Vlasova and Tamara Ivanovna Godovikova and Sergei Grigorievich Zlotin and Oleg Alexeevich Rakitin},
title = {Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan},
journal = {Mendeleev Communications},
year = {2017},
volume = {27},
publisher = {Mendeleev Communications},
month = {Sep},
url = {https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.09.005},
number = {5},
pages = {448--450},
doi = {10.1016/j.mencom.2017.09.005}
}
MLA
Cite this
MLA Copy
Troitskaya-Markova, Nadezhda A., et al. “Bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan.” Mendeleev Communications, vol. 27, no. 5, Sep. 2017, pp. 448-450. https://mendcomm.colab.ws/publications/10.1016/j.mencom.2017.09.005.

Abstract

The novel heterocyclic system, bis[1,2,5]oxadiazolo[3,4-c:3’,4’-e]pyridazine 4,5-dioxide, was obtained along with other products in the course of oxidation of 3,3’-bi-1,2,5-oxadiazole-4,4’-diamine. This compound acts as a synthetic equivalent of 4,4’-dinitroso-3,3’-bifurazan affording bis-diazene oxide derivative in the Kovacic reaction.

References

1.
Nitrates and Other Nitric Oxide Donors in Cardiology - Current Positioning and Perspectives
Iachini Bellisarii F., Radico F., Muscente F., Horowitz J., De Caterina R.
Cardiovascular Drugs and Therapy, 2011
2.
Recent developments in nitric oxide donor drugs
Miller M.R., Megson I.L.
British Journal of Pharmacology, 2007
3.
NO at work
Schmidt H.H., Walter U.
Cell, 1994
4.
The arginine-nitric oxide pathway: A target for new drugs
Kerwin J.F., Heller M.
Medicinal Research Reviews, 1994
5.
Ananikov V.P., Khokhlova E.A., Egorov M.P., Sakharov A.M., Zlotin S.G., Kucherov A.V., Kustov L.M., Gening M.L., Nifantiev N.E.
Mendeleev Communications, 2015
6.
Zlotin S.G., Churakov A.M., Luk’yanov O.A., Makhova N.N., Sukhorukov A.Y., Tartakovsky V.A.
Mendeleev Communications, 2015
7.
Bastrakov M.A., Starosotnikov A.M., Fedyanin I.V., Kachala V.V., Shevelev S.A.
Mendeleev Communications, 2014
8.
Fershtat L.L., Epishina M.A., Kulikov A.S., Makhova N.N.
Mendeleev Communications, 2015
9.
An efficient access to (1H-tetrazol-5-yl)furoxan ammonium salts via a two-step dehydration/[3+2]-cycloaddition strategy
Fershtat L.L., Epishina M.A., Kulikov A.S., Ovchinnikov I.V., Ananyev I.V., Makhova N.N.
Tetrahedron, 2015
10.
Konstantinova L.S., Amelichev S.A., Zlotin S.G., Struchkova M.I., Godovikova T.I., Rakitin O.A.
Mendeleev Communications, 2015
12.
Fershtat L.L., Ashirbaev S.S., Kulikov A.S., Kachala V.V., Makhova N.N.
Mendeleev Communications, 2015
13.
Design of hybrid heterocyclic systems with a furoxanylpyridine core via tandem hetero-Diels-Alder/retro-Diels-Alder reactions of (1,2,4-triazin-3-yl)furoxans
Fershtat L.L., Larin A.A., Epishina M.A., Ovchinnikov I.V., Kulikov A.S., Ananyev I.V., Makhova N.N.
RSC Advances, 2016
15.
Regioselective synthesis of bifuroxanyl systems with the 3-nitrobifuroxanyl core via a one-pot acylation/nitrosation/cyclization cascade
Fershtat L.L., Larin A.A., Epishina M.A., Kulikov A.S., Ovchinnikov I.V., Ananyev I.V., Makhova N.N.
Tetrahedron Letters, 2016
17.
M. D. Dutov, Yu. V. Khropov, A. Ya. Kots, N.N. Belushkina, O.G. Busygina, I.S. Severina and S. A. Shevelev, Patent RU 2122582, 1997.
19.
Thiol-Induced Nitric Oxide Release from 3-Halogeno-3,4-dihydrodiazete 1,2-Dioxides
Kirilyuk I.A., Utepbergenov D.I., Mazhukin D.G., Fechner K., Mertsch K., Khramtsov V.V., Blasig I.E., Haseloff R.F.
Journal of Medicinal Chemistry, 1998
20.
Vasorelaxant and antiplatelet activity of 4,7-dimethyl-1,2,5-oxadiazolo[3,4-d]pyridazine 1,5,6-trioxide: Role of soluble guanylate cyclase, nitric oxide and thiols
Kots A.Y., Grafov M.A., Khropov Y.V., Betin V.L., Belushkina N.N., Busygina O.G., Yazykova M.Y., Ovchinnikov I.V., Kulikov A.S., Makhova N.N., Medvedeva N.A., Bulargina T.V., Severina I.S.
British Journal of Pharmacology, 2000
21.
Nitric Oxide and Cyclic GMP Signaling Pathway as a Focus for Drug Development
Kots A.Y., Bian K., Murad F.
Current Medicinal Chemistry, 2011
23.
4,5-Dimethyl-9,10-diazaphenanthrene N,N'-dioxide
Whittleton S.N., Dunitz J.D.
Acta Crystallographica Section B, 1982
24.
The synthesis of benzo[c] cinnoline dioxides
Kempter F.E., Castle R.N.
Journal of Heterocyclic Chemistry, 2009
25.
Preparation of ring-fused pyridazines by reduction of 3,3′-dinitro-4,4′-bipyridyl and 3,3′-dinitro-4,4′-biquinolyl
Kanoktanaporn S., MacBride J.A.
Journal of the Chemical Society Perkin Transactions 1, 1978
26.
10.1016/j.mencom.2017.09.005_bib0130
Nonciaux
Bull. Soc. Chim. Fr., 1973
27.
The synthesis of 3-nitroso-4-R-furazanes
Sheremetev A.B., Novikova T.S., Mel'nikova T.M., Khmel'nitskii L.I.
Russian Chemical Bulletin, 1990
28.
Sulfonyldiazene-N-oxides
Khodot E.N., Svirskaya L.G., Chlenov I.E.
Russian Chemical Bulletin, 1994
29.
Mel’nikova T.M., Novikova T.S., Khmel’nitskii L.I., Sheremetev A.B.
Mendeleev Communications, 2001
31.
Furazane disulfilimines
Vlasova O.G., Rakitin O.A., Khmel'nitskii L.I.
Russian Chemical Bulletin, 1992
33.
Sulfyliminofuroxans: Synthesis, structure, and oxidation to nitro and nitroso derivatives
Rakitin O.A., Vlasova O.G., Chertanova L.F., Khmel'nitskii L.I.
Russian Chemical Bulletin, 1990
34.
Oxidations of 3,6-diamino-1,2,4,5-tetrazine and 3,6-bis(s,s-dimethylsulfilimino)-1,2,4,5-tetrazine
Coburn M.D., Hiskey M.A., Lee K.-., Ott D.G., Stinecipher M.M.
Journal of Heterocyclic Chemistry, 1993
35.
Synthesis of N?-methoxydiazene N-oxides from methoxyamine and nitroso compounds
Luk'yanov O.A., Smirnov G.A., Vasil'ev A.M.
Russian Chemical Bulletin, 1990
37.
Nucleophilic substitution in the furazan series. Reactions of nitrofurazans with ammonia
Sheremetev A.B., Kulagina V.O., Kryazhevskikh I.A., Melnikova T.M., Aleksandrova N.S.
Russian Chemical Bulletin, 2002